Skip to main content

Reply to M.C. Chamberlain

Publication ,  Journal Article
Heimberger, AB; Bigner, DD; Herndon, JE; Sampson, JH
Published in: Journal of Clinical Oncology
June 10, 2011

Duke Scholars

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 10, 2011

Volume

29

Issue

17

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Heimberger, A. B., Bigner, D. D., Herndon, J. E., & Sampson, J. H. (2011). Reply to M.C. Chamberlain. Journal of Clinical Oncology, 29(17). https://doi.org/10.1200/JCO.2010.34.1453
Heimberger, A. B., D. D. Bigner, J. E. Herndon, and J. H. Sampson. “Reply to M.C. Chamberlain.” Journal of Clinical Oncology 29, no. 17 (June 10, 2011). https://doi.org/10.1200/JCO.2010.34.1453.
Heimberger AB, Bigner DD, Herndon JE, Sampson JH. Reply to M.C. Chamberlain. Journal of Clinical Oncology. 2011 Jun 10;29(17).
Heimberger, A. B., et al. “Reply to M.C. Chamberlain.” Journal of Clinical Oncology, vol. 29, no. 17, June 2011. Scopus, doi:10.1200/JCO.2010.34.1453.
Heimberger AB, Bigner DD, Herndon JE, Sampson JH. Reply to M.C. Chamberlain. Journal of Clinical Oncology. 2011 Jun 10;29(17).

Published In

Journal of Clinical Oncology

DOI

EISSN

1527-7755

ISSN

0732-183X

Publication Date

June 10, 2011

Volume

29

Issue

17

Related Subject Headings

  • Oncology & Carcinogenesis
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences